West Pharmaceutical Services Inc (WST)
Fixed asset turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 2,893,200 | 2,949,800 | 2,886,900 | 2,831,600 | 2,146,900 |
Property, plant and equipment | US$ in thousands | — | — | 1,158,300 | 1,057,500 | 943,200 |
Fixed asset turnover | — | — | 2.49 | 2.68 | 2.28 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $2,893,200K ÷ $—K
= —
The fixed asset turnover ratio for West Pharmaceutical Services Inc has been fluctuating over the past few years. In 2020, the ratio was 2.28, indicating that the company generated $2.28 in revenue for every dollar invested in fixed assets. This ratio increased to 2.68 in 2021, suggesting an improvement in the company's efficiency in utilizing its fixed assets to generate sales.
However, in 2022, the fixed asset turnover ratio decreased to 2.49, which could indicate a slight decline in efficiency in generating revenue from fixed assets compared to the previous year. Unfortunately, data is not available for 2023 and 2024, making it difficult to assess the trend further.
Overall, while the company's fixed asset turnover ratio has shown some fluctuations, it is essential for West Pharmaceutical Services Inc to monitor and improve this ratio to ensure optimal utilization of its fixed assets in generating revenue.
Peer comparison
Dec 31, 2024